Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Red Light Holland ( (TSE:TRIP) ) just unveiled an announcement.
Red Light Holland reported third-quarter 2026 results showing an 8.3% year-over-year revenue increase to $1.27 million, but a 13.7% decline in gross profit and a slightly higher adjusted EBITDA loss of $0.71 million, while cash fell to $9.24 million amid investment in Bitcoin ETFs and high-interest savings vehicles. Management highlighted normalized sales versus the prior quarter, lower G&A expenses, the shutdown of shiitake mushroom production at AEM to focus on near-profitable operations, and progress in psilocybin R&D through its DEA-registered partner Irvine Labs, underscoring a strategic pivot toward an R&D-driven model and active evaluation of M&A from a relatively strong balance-sheet position.
The most recent analyst rating on (TSE:TRIP) stock is a Hold with a C$0.02 price target. To see the full list of analyst forecasts on Red Light Holland stock, see the TSE:TRIP Stock Forecast page.
Spark’s Take on TSE:TRIP Stock
According to Spark, TipRanks’ AI Analyst, TSE:TRIP is a Underperform.
The overall stock score of 40 reflects significant financial challenges, including declining revenues and substantial losses. Technical analysis indicates a bearish trend with weak momentum. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, further impacting the stock’s attractiveness.
To see Spark’s full report on TSE:TRIP stock, click here.
More about Red Light Holland
Red Light Holland is an Ontario-based company operating in the legal psychedelic sector, focused on consensual data collection and R&D to advance naturally occurring drug development and understanding of psilocybin use and consumer experiences. It runs commercial operations in Europe and North America, including psilocybin truffle sales in the Netherlands’ legal market and mushroom home grow kits sold through B2B and direct-to-consumer channels, in compliance with applicable laws.
Average Trading Volume: 212,959
Technical Sentiment Signal: Sell
Current Market Cap: C$6.34M
Find detailed analytics on TRIP stock on TipRanks’ Stock Analysis page.